Chemoinformaics analysis of Dihydroxytetramethoxyflavone
| Molecular Weight | 412.702 | nRot | 5 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 1 |
| Exact Molecular Weight | 412.371 | nRing | 4 |
| Solubility: LogS | -5.222 | nHRing | 0 |
| Solubility: LogP | 5.499 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 81.2381 |
| nHD | 1 | BPOL | 48.1539 |
| QED | 0.433 |
| Synth | 2.181 |
| Natural Product Likeliness | 0.81 |
| NR-PPAR-gamma | 0.128 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.08 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.582 |
| MDCK | 0.0000142 |
| BBB | 0.896 |
| PPB | 0.972752 |
| VDSS | 1.684 |
| FU | 0.0077599 |
| CYP1A2-inh | 0.888 |
| CYP1A2-sub | 0.196 |
| CYP2c19-inh | 0.821 |
| CYP2c19-sub | 0.081 |
| CYP2c9-inh | 0.447 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.05 |
| CYP2d6-sub | 0.089 |
| CYP3a4-inh | 0.274 |
| CYP3a4-sub | 0.069 |
| CL | 6.928 |
| T12 | 0.332 |
| hERG | 0.02 |
| Ames | 0.011 |
| ROA | 0.035 |
| SkinSen | 0.954 |
| Carcinogencity | 0.536 |
| EI | 0.961 |
| Respiratory | 0.907 |
| NR-Aromatase | 0.183 |
| Antiviral | No |
| Prediction | 0.707251 |